- For the management of Postherpetic Neuralgia (PHN).
Coverage of drugs is first determined by the memberís pharmacy or medical benefit. Please consult with or refer to the Evidence of Coverage document.
|Drug||Dosing Regimen||Dose Limit/ Maximum Dose|
300 to 3600 mg PO TID
3600 mg per day
|Drug||Dosing Regimen||Authorization Limit|
Initial dose of 300 mg PO QD and titrate to 1800 mg PO QD over two weeks
Length of benefit